Peroxisome proliferator-activated receptor gamma ligand pioglitazone alters neointimal composition in a balloon-denuded and radiated hypercholesterolemic rabbit.

作者: Rajbabu Pakala , Christian Dilcher , Richard Baffour , David Hellinga , Rufus Seabron

DOI: 10.1097/01.FJC.0000249891.40714.2A

关键词:

摘要: Peroxisome proliferator-activated receptor (PPAR)-gamma activation suppresses inflammatory response, monocyte recruitment, and vascular cell proliferation. Because inflammation, deregulated growth, migration of monocytes smooth muscle cells (VSMC) play important roles in the development neointima, we tested effect pioglitazone, a high-affinity ligand, for PPAR-gamma on neointima formation iliac arteries balloon-denuded radiated hypercholesterolemic rabbit. Rabbits were fed 1.0% cholesterol diet 7 days followed by denudation endothelial layer continued 0.15% diet. On day 32, animals divided into 2 groups. One group received (n = 7) other supplemented with 400 mg pioglitazone per kilogram. 35, area was radiated. Four weeks after radiation, sacrificed arterial segments processed morphometry immunohistochemistry. Data analysis showed that had smaller (0.85 +/- 0.36 vs. 1.41 0.56, P < 0.05), more positive VSMC (23.07 6.16 18.33 5.19, 0.04), less (16.01 5.33 21.29 4.33, fewer expressing metalloproteinase (MMP)-1 MMP-9 (3.69 0.47 4.82 0.93, 0.05 3.24 0.71 4.29 0.74, 0.05, respectively). Pioglitazone reduced neointimal modified its composition rabbit model.

参考文章(48)
Rajbabu Pakala, Laurent Leborgne, Edouard Cheneau, Rosanna C. Chan, Hamid Yazdi, Jana Fournadjiev, Deena Weber, David Hellinga, Frank Kolodgie, Renu Virmani, Ron Waksman, Radiation-Induced Atherosclerotic Plaque Progression in a Hypercholesterolemic Rabbit: A Prospective Vulnerable Plaque Model? Cardiovascular Radiation Medicine. ,vol. 4, pp. 146- 151 ,(2003) , 10.1016/S1522-1865(03)00182-3
Tsutomu Takagi, Takashi Akasaka, Atsushi Yamamuro, Yasuhiro Honda, Takeshi Hozumi, Shigefumi Morioka, Kiyoshi Yoshida, Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non–insulin dependent diabetes mellitus: A serial intravascular ultrasound study Journal of the American College of Cardiology. ,vol. 36, pp. 1529- 1535 ,(2000) , 10.1016/S0735-1097(00)00895-0
Robert B. Clark, David Bishop-Bailey, Tatiana Estrada-Hernandez, Timothy Hla, Lynn Puddington, Steven J. Padula, The Nuclear Receptor PPARγ and Immunoregulation: PPARγ Mediates Inhibition of Helper T Cell Responses The Journal of Immunology. ,vol. 164, pp. 1364- 1371 ,(2000) , 10.4049/JIMMUNOL.164.3.1364
Giulia Chinetti, Sophie Lestavel, Virginie Bocher, Alan T. Remaley, Bernadette Neve, Inés Pineda Torra, Elisabeth Teissier, Anne Minnich, Michael Jaye, Nicolas Duverger, H. Bryan Brewer, Jean-Charles Fruchart, Véronique Clavey, Bart Staels, PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nature Medicine. ,vol. 7, pp. 53- 58 ,(2001) , 10.1038/83348
Bart Staels, Wolfgang Koenig, Aïda Habib, Régine Merval, Marilyne Lebret, Inés Pineda Torra, Philippe Delerive, Abdessamad Fadel, Giulia Chinetti, Jean-Charles Fruchart, Jamila Najib, Jacques Maclouf, Alain Tedgui, Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators Nature. ,vol. 393, pp. 790- 793 ,(1998) , 10.1038/31701
Z. Levi, A. Shaish, N. Yacov, H. Levkovitz, S. Trestman, Y. Gerber, H. Cohen, A. Dvir, R. Rhachmani, M. Ravid, D. Harats, Rosiglitazone (PPARγ‐agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes–atherosclerosis mouse model Diabetes, Obesity and Metabolism. ,vol. 5, pp. 45- 50 ,(2003) , 10.1046/J.1463-1326.2003.00240.X
Mercedes Ricote, Andrew C. Li, Timothy M. Willson, Carolyn J. Kelly, Christopher K. Glass, The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation Nature. ,vol. 391, pp. 79- 82 ,(1998) , 10.1038/34178
Chengyu Jiang, Adrian T. Ting, Brian Seed, PPAR-γ agonists inhibit production of monocyte inflammatory cytokines Nature. ,vol. 391, pp. 82- 86 ,(1998) , 10.1038/34184
Alan R. Collins, Woerner P. Meehan, Ulrich Kintscher, Simon Jackson, Shu Wakino, Grace Noh, Wulf Palinski, Willa A. Hsueh, Ronald E. Law, Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 21, pp. 365- 371 ,(2001) , 10.1161/01.ATV.21.3.365